Report interim analysis of the phase 3 pivotal LUNAR trial in non-small cell lung cancer
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 11 Jan 2021
- Due
- 31 Dec 2021
- Checked
- 25 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Interim analysis of phase 3 pivotal LUNAR trial in non-small cell lung cancer (2021)”
What we found
Evidence strength A What the grades mean
The company did not report an interim analysis of the LUNAR trial in 2021; instead, it completed enrollment in November 2021 and reported top-line results in early 2023.
-
A NovoCure Ltd 8-K filed 2022-02-24
“In November, we announced the last patient had been enrolled in our phase 3 pivotal LUNAR study for the treatment of non-small cell lung cancer (“NSCLC”). Patients will be followed for 12 months with top-line data expected by year-end 2022.” ✓ confirmed on the page
-
A NovoCure Ltd 10-K filed 2023-02-23
“We recently completed patient follow-up and announced top line results from our pivotal LUNAR study” ✓ confirmed on the page
Market reaction: the shares moved +8.7% against the S&P 500 over the three sessions around the disclosure (23 Feb 2022 to 28 Feb 2022). What this measures
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- LUNAR trial interim analysis
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you NovoCure Ltd? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-NVCR-021850 · Corrections policy